CytomX Therapeutics Inc (NASDAQ:CTMX)

1.33
Delayed Data
As of 3:59pm ET
 -0.02 / -1.48%
Today’s Change
1.04
Today|||52-Week Range
3.02
-16.87%
Year-to-Date
Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine
11:56am / Zacks.com - Paid Partner Content
CRISPR (CRSP) Rises More Than 40% in Past 3 Months: Here's Why
Nov 24 / Zacks.com - Paid Partner Content
Immunovant (IMVT) Up on Positive Initial IMVT-1402 MAD Study Data
10:22am / Zacks.com - Paid Partner Content
Vertex (VRTX) Gets EU Nod for Kaftrio Use in 2-5 Year Kids
Nov 24 / Zacks.com - Paid Partner Content
SpringWorks (SWTX) Rises on FDA Nod for Desmoid Tumor Drug
10:20am / Zacks.com - Paid Partner Content
Freeline (FRLN) Shares Rise on Merger Agreement With Syncona
Nov 23 / Zacks.com - Paid Partner Content
Xenon (XENE) Up on Top-Line Data From MDD Drug Phase II Study
Nov 28 / Zacks.com - Paid Partner Content
Immix (IMMX) CAR-T Therapy IND Cleared by FDA, Stock Down
Nov 22 / Zacks.com - Paid Partner Content
TC BioPharm (TCBP) Falls Despite FDA Clearing IND for AML Drug
Nov 28 / Zacks.com - Paid Partner Content
Here's Why You May Invest in Puma Biotechnology (PBYI) Stock
Nov 20 / Zacks.com - Paid Partner Content
GSK's Blenrep Combo Meets PFS Endpoint in Head-to-Head Study
Nov 27 / Zacks.com - Paid Partner Content